TARS R&D Expenses
Tarsus Pharmaceuticals Inc · R&D Expenses
TARS R&D Expenses
Latest reported$87.68Mperiod ending
TARS TTM R&D Expenses ($1.55M → $87.68M)
TTM R&D Expenses
High-resolution chart · PNG
TARS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 87,679,999 | |
| 72,263,999 | |
| 64,321,999 | |
| 63,159,999 | |
| 59,004,000 | |
| 55,729,000 | |
| 53,386,000 | |
| 49,818,000 | |
| 49,795,000 | |
| 50,022,000 | |
| 50,312,000 | |
| 47,035,000 | |
| 45,842,000 | |
| 42,899,000 | |
| 42,624,000 | |
| 40,634,000 | |
| 39,931,000 | |
| 37,532,000 | |
| 41,712,000 | |
| 41,261,000 | |
| 39,043,000 | |
| 33,576,000 | |
| 18,827,000 | |
| 11,937,000 | |
| 4,345,000 | |
| 2,833,250 | |
| 1,546,500 |